Mori H
Department of Neuroscience, Osaka City University Medical School.
Rinsho Shinkeigaku. 2001 Dec;41(12):1104-6.
We have developed five tau antibodies that recognize each of 6 human tau isoforms to examine tau lesions such as Alzheimer's neurofibrillary tangles (NFTs) in Alzheimer's disease (AD) as well as other tauopachies. These five antibodies were designed to be specific to splicing-sites of exon 2, exon 3, or exon10 or to the amino acid sequence in exon 3 or exon10. All of newly prepared antibodies as well as anti-human tau stained corresponding recombinant tau isoforms and isolated hyperphosphorylated tau isoforms in an isoform-specific manner on western blot. All antibodies were also found to decorate immunohistochemically NFTs but to be present in unequal amounts in NFTs where two tau isoforms (tau1-352 and tau1-381) were the major species. It is not easy to compare immunoreaction based on immunohistochemical analysis with multiple antibodies. However, the present result strongly suggest unequal occurrence of tau isoforms in Alzheimer's NFTs, indicating other isoform selection in AD than tauopathies.
我们研发了五种tau抗体,它们能识别6种人类tau异构体中的每一种,以检测tau病变,如阿尔茨海默病(AD)中的阿尔茨海默神经原纤维缠结(NFTs)以及其他tau蛋白病。这五种抗体被设计为对2号外显子、3号外显子或10号外显子的剪接位点,或3号外显子或10号外显子中的氨基酸序列具有特异性。所有新制备的抗体以及抗人tau抗体在蛋白质印迹上以异构体特异性方式对相应的重组tau异构体和分离的高度磷酸化tau异构体进行染色。还发现所有抗体均能免疫组化标记NFTs,但在NFTs中含量不等,其中两种tau异构体(tau1 - 352和tau1 - 381)是主要类型。基于免疫组化分析用多种抗体比较免疫反应并不容易。然而,目前的结果强烈表明阿尔茨海默病NFTs中tau异构体的出现情况不同,这表明AD中存在不同于tau蛋白病的其他异构体选择。